Phase I Study of Venetoclax Plus DA-EPOCH-R for the Treatment of Aggressive B-Cell Lymphomas
Phase of Trial: Phase I
Latest Information Update: 28 May 2018
At a glance
- Drugs Venetoclax (Primary) ; Cyclophosphamide; Doxorubicin; Etoposide; Prednisone; Rituximab; Vincristine
- Indications B-cell lymphoma; Diffuse large B cell lymphoma; Non-Hodgkin's lymphoma
- Focus Adverse reactions
- Acronyms V+DA-EPOCH-R
- 18 May 2018 Planned primary completion date changed from 1 Feb 2018 to 1 Feb 2019.
- 26 Apr 2017 Status changed from not yet recruiting to recruiting.
- 03 Feb 2017 New trial record